Italia - italiensk - AIFA (Agenzia Italiana del Farmaco)

savio pharma italia s.r.l. - mucolitici - mucolitici

Italia - italiensk - AIFA (Agenzia Italiana del Farmaco)

istituto chimico internazionale dr.giuseppe rende s.r.l. - mucolitici - mucolitici

Italia - italiensk - AIFA (Agenzia Italiana del Farmaco)

laboratorio farmaceutico sit specialita igienico terapeutiche s.r.l. - mucolitici - mucolitici

Italia - italiensk - AIFA (Agenzia Italiana del Farmaco)

actavis group ptc ehf - mucolitici - mucolitici

Den europeiske union - italiensk - EMA (European Medicines Agency)

incyte biosciences distribution b.v. - ruxolitinib phosphate - vitiligo - altri preparati dermatologici - opzelura is indicated for the treatment of non-segmental vitiligo with facial involvement in adults and adolescents from 12 years of age.

Den europeiske union - italiensk - EMA (European Medicines Agency)

novartis europharm limited - ruxolitinib (come fosfato) - myeloproliferative disorders; polycythemia vera; graft vs host disease - agenti antineoplastici - myelofibrosis (mf)jakavi is indicated for the treatment of disease related splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idiopathic myelofibrosis), post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis. policitemia vera (pv)jakavi è indicato per il trattamento di pazienti adulti affetti da policitemia vera, che sono resistenti o intolleranti di hydroxyurea. graft versus host disease (gvhd)jakavi is indicated for the treatment of patients aged 12 years and older with acute graft versus host disease or chronic graft versus host disease who have inadequate response to corticosteroids or other systemic therapies (see section 5.

Den europeiske union - italiensk - EMA (European Medicines Agency)

pfizer limited - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - agenti antineoplastici - gastrointestinal stromal tumour (gist)sutent is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib mesilate treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults. experience with sutent as first-line treatment is limited (see section 5.

Italia - italiensk - AIFA (Agenzia Italiana del Farmaco)

teofarma s.r.l. - sedativi della tosse e mucolitici - sedativi della tosse e mucolitici

Italia - italiensk - AIFA (Agenzia Italiana del Farmaco)

laboratorio farmaceutico sit specialita igienico terapeutiche s.r.l. - mucolitici - mucolitici

Italia - italiensk - AIFA (Agenzia Italiana del Farmaco)

boehringer ingelheim italia s.p.a. - mucolitici - mucolitici